Abbaspour Mohammadreza, Jalayer Negar, Sharif Makhmalzadeh Behzad
Nanotechnology Research Center and school of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Adv Pharm Bull. 2014;4(2):113-9. doi: 10.5681/apb.2014.018. Epub 2013 Dec 24.
Recently the liquid nanoemulsifying drug delivery systems (SNEDDS) have shown dramatic effects on improving oral bioavailability of poorly soluble drugs. The main purpose of this study was to prepare a solid form of self-nanoemulsifying drug delivery system of loratadin by extrusion-spheronization. The liquid SNEDDS are generally prepared in a soft or hard gelatin capsules which suffers from several disadvantages. Therefore incorporation of SNEDDS into solid dosage form is desirable to get together the advantages of SNEDDS and solid multiparticualte systems.
The SNEDDS was consisted of liquid paraffin, capriole, span 20, transcutol and loratadin as a poorly soluble drug. A multilevel factorial design was used to formulation of SNEDDS pellets, liquid SNEDDS (20 and 30%) was mixed with lactose, microcrystallin cellulose (40%) and silicon dioxide (0, 5 and 10%), and Na- crosscarmelose (0, 5 and 10%). The resulting wet mass transformed into pellets by extrusion-spheronization. The pellets were dried and characterized for size (sieve analysis), shape (image analysis), mechanical strength (friability test), droplet size (laser light scattering) and drug release rate (dissolution test). Selected SNEDDS pellets were also compared with conventional loratadin pellet or tablet formulation.
The resulting SNE pellets exhibited uniform size and shape. Total friability of pellets did not affected by formulation variables. The in vitro release of SNE pellets was higher than the liquid SNE and powder tablets.
Our studies demonstrated that extrusion-spheronization is a viable technology to produce self-emulsifying pellets in large scale which can improve in vitro dissolution with better solubility.
近年来,液体纳米乳化药物递送系统(SNEDDS)在提高难溶性药物口服生物利用度方面显示出显著效果。本研究的主要目的是通过挤出滚圆法制备氯雷他定自纳米乳化药物递送系统的固体剂型。液体SNEDDS通常制备在软胶囊或硬胶囊中,存在几个缺点。因此,将SNEDDS纳入固体剂型是可取的,以便兼具SNEDDS和固体多颗粒系统的优点。
SNEDDS由液体石蜡、辛酸癸酸甘油三酯、司盘20、二甘醇单乙醚和作为难溶性药物的氯雷他定组成。采用多水平析因设计来制备SNEDDS微丸,将液体SNEDDS(20%和30%)与乳糖、微晶纤维素(40%)和二氧化硅(0、5%和10%)以及交联羧甲基纤维素钠(0、5%和10%)混合。所得湿物料通过挤出滚圆法制成微丸。微丸干燥后进行粒度(筛分分析)、形状(图像分析)、机械强度(脆碎度试验)、液滴大小(激光散射)和药物释放速率(溶出度试验)表征。还将选定的SNEDDS微丸与传统氯雷他定微丸或片剂剂型进行了比较。
所得SNE微丸呈现出均匀的大小和形状。微丸的总脆碎度不受配方变量的影响。SNE微丸的体外释放高于液体SNE和粉末片剂。
我们的研究表明,挤出滚圆法是一种可行的大规模生产自乳化微丸的技术,可提高体外溶出度且溶解性更好。